Abstract Background Genetic heterogeneity of a cancer tumor that develops during clonal evolution is one of the reasons for cancer treatment failure, by increasing the chance of drug resistance. Clones are cell populations with different genotypes, resulting from differences in somatic mutations that occur and accumulate during cancer development. An appropriate approach for identifying clones is determining the variant allele frequency of mutations that occurred in the tumor. Although bulk sequencing data can be used to provide that information, the frequencies are not informative enough for identifying different clones with the same prevalence and their evolutionary relationships. On the other hand, single-cell sequencing data provides va...
Clonal deconvolution of mutational landscapes is crucial to understand the evolutionary dynamics of ...
Abstract Background High-throughput sequencing allows...
Abstract Background High-throughput sequencing allows...
Tumour development has long been recognised as an evolutionary process during which cells accumulate...
Cancer is a genetic disease characterized by the emergence of genetically distinct populations of ce...
Cancers are composed of genetically distinct subpopulations of malignant cells. By sequencing DNA fr...
Intra-tumor heterogeneity presents itself through the evolution of subclones during cancer progressi...
Improving our understanding of intra-tumour heterogeneity in cancer has important clinical implicati...
BACKGROUND: Every tumor is composed of heterogeneous clones, each corresponding to a distinct subpop...
Cancer is a complex, adaptive system characterized by constantly evolving subclonal populations of c...
Emerging ultra-low coverage single-cell DNA sequencing (scDNA-seq) technologies have enabled high re...
Every tumor is composed of heterogeneous clones, each corresponding to a distinct subpopulation of c...
An accurate phylogeny of a cancer tumour has the potential to shed light on numerous phenomena, such...
An accurate phylogeny of a cancer tumour has the potential to shed light on numerous phenomena, such...
<div><p>Cancers arise from successive rounds of mutation and selection, generating clonal population...
Clonal deconvolution of mutational landscapes is crucial to understand the evolutionary dynamics of ...
Abstract Background High-throughput sequencing allows...
Abstract Background High-throughput sequencing allows...
Tumour development has long been recognised as an evolutionary process during which cells accumulate...
Cancer is a genetic disease characterized by the emergence of genetically distinct populations of ce...
Cancers are composed of genetically distinct subpopulations of malignant cells. By sequencing DNA fr...
Intra-tumor heterogeneity presents itself through the evolution of subclones during cancer progressi...
Improving our understanding of intra-tumour heterogeneity in cancer has important clinical implicati...
BACKGROUND: Every tumor is composed of heterogeneous clones, each corresponding to a distinct subpop...
Cancer is a complex, adaptive system characterized by constantly evolving subclonal populations of c...
Emerging ultra-low coverage single-cell DNA sequencing (scDNA-seq) technologies have enabled high re...
Every tumor is composed of heterogeneous clones, each corresponding to a distinct subpopulation of c...
An accurate phylogeny of a cancer tumour has the potential to shed light on numerous phenomena, such...
An accurate phylogeny of a cancer tumour has the potential to shed light on numerous phenomena, such...
<div><p>Cancers arise from successive rounds of mutation and selection, generating clonal population...
Clonal deconvolution of mutational landscapes is crucial to understand the evolutionary dynamics of ...
Abstract Background High-throughput sequencing allows...
Abstract Background High-throughput sequencing allows...